Clinitech Laboratory

Clinitech Laboratory

41.75
-0.05
(-0.12%)
ann
There are new updates from the company4 hours ago
Viewcross
right
hide
Key Fundamentals
Add Ratio
Market Cap
9.50 Cr
EPS
1.90
PE Ratio
24.16
Dividend Yield
0.00 %
52 Week High
98.99
52 Week Low
29.15
PB Ratio
1.08
Debt to Equity
0.07
Forecast For
Actual

Company News

View All News
Caret
positive
Clinitech Laboratory Limited has signed a Memorandum of Understanding with MDM Dawudi Hospital Pvt Ltd to collaborate and operate a diagnostic centre named CTL Dombivli. The partnership aims to jointly develop, manage and expand pathology and radiology services in the region.
neutral
Clinitech Laboratory Limited reported unaudited financial results for the half year ended September 30, 2025. The company's revenue from operations increased to Rs 508.02 lakhs compared to Rs 415.89 lakhs in the previous quarter and Rs 407.60 lakhs in the corresponding period last year. However, profit after tax declined to Rs 21.41 lakhs from Rs 29.43 lakhs in the previous quarter, though it improved from Rs 35.16 lakhs loss in the same period last year. The Board of Directors also approved the formation of a subsidiary company. The company operates in pathology and related healthcare services. As of September 30, 2025, the company had partially utilized Rs 428.30 lakhs out of Rs 578.30 lakhs raised through its IPO, with Rs 150 lakhs remaining unutilized from the diagnostic business expansion allocation.
neutral
Clinitech Laboratory Promoter Jagdish Nayak Acquires 8,400 Additional SharesSep 27, 2025
Jagdish Umakant Nayak, promoter and managing director of Clinitech Laboratory Limited, purchased 8,400 equity shares on September 26, 2025, through open market transactions. The acquisition increased his shareholding from 6,85,300 shares (30.03%) to 6,93,700 shares (30.39%) of the company's total equity capital of 22,82,400 shares. The transaction represents a 0.37% increase in his stake. Clinitech Laboratory is listed on the Bombay Stock Exchange under the symbol CTLLAB.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
3,158.30
#1 26,416.10
48.94
#1 2,554.80
11.28
#1 492
16.36
52.08
1,039.40
10,893.00
71.60
699.70
23.06
144
2.85
57.88
1,982.30
10,210.20
64.37
1,346.30
10.64
146
13.28
50.35
1,552.80
8,288.30
65.54
702.20
20.80
91
81.06
73.52
826.80
2,615.20
30.88
742.70
16.70
78
22.45
56.60
301.90
1,615.00
52.01
255.90
15.11
31
-13.73
40.22
1,326.35
1,194.60
24.36
111.60
28.72
48
0.67
44.14
300.20
909.00
#1 -6.10
1,170.80
-18.47
-134
90.05
51.72
440.50
819.90
30.87
147.80
#1 134.60
19
#1 760.87
72.80
142.90
97.60
65.44
41.80
13.28
2
100.00
42.21
Growth Rate
Revenue Growth
32.81 %
Net Income Growth
-
Cash Flow Change
31.25 %
ROE
-57.27 %
ROCE
-55.09 %
EBITDA Margin (Avg.)
-22.24 %

Yearly Financial Results

Annual Financials
2021
2022
2023
2024
2025
TTM
Revenue
5
7
6
6
9
0
Expenses
4
5
5
5
7
0
EBITDA
1
1
1
1
1
0
Operating Profit %
18 %
17 %
21 %
16 %
10 %
0 %
Depreciation
0
0
0
0
0
0
Interest
0
0
0
0
0
0
Profit Before Tax
1
1
1
1
1
0
Tax
0
0
0
0
0
0
Net Profit
0
1
1
0
0
0
EPS in ₹
6.04
3.42
4.09
2.37
1.90
0.00

Balance Sheet

Balance Sheet
2021
2022
2023
2024
2025
Total Assets
3
4
6
6
11
Fixed Assets
1
2
1
2
2
Current Assets
2
1
2
3
7
Capital Work in Progress
0
0
1
1
1
Investments
0
0
0
0
0
Other Assets
2
2
4
3
8
Total Liabilities
3
4
6
6
11
Current Liabilities
1
1
2
2
2
Non Current Liabilities
1
1
2
0
0
Total Equity
1
2
2
4
9
Reserve & Surplus
1
0
1
2
7
Share Capital
1
2
2
2
2

Cash Flow

Cash Flow
2021
2022
2023
2024
2025
Net Cash Flow
0
-0
1
-0
2
Investing Activities
1
-2
-1
1
-1
Operating Activities
0
1
1
-1
-1
Financing Activities
-1
0
0
0
4

Share Holding

% Holding
Jan 2024
Jul 2024
Sept 2024
Mar 2025
Sept 2025
Promoter
83.63 %
61.58 %
61.58 %
61.58 %
62.42 %
FIIs
0.00 %
0.32 %
0.32 %
0.32 %
0.32 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
33.81 %
35.91 %
36.28 %
35.91 %
Others
16.37 %
4.30 %
2.20 %
1.83 %
1.36 %
No of Share Holders
24
450
346
303
303

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
13 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2024 80.99 80.00
23 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 May 2025 42.71 42.71
23 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
23 Sept 2025 52.40 44.80
12 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Nov 2025 42.00 44.00

Announcements

General Update W.R.T Memorandum Of Understanding ("MOU") Entered4 hours ago
Statement Of Deviation & Variation As On September 30 20255 days ago
Financials Results For 30.09.20255 days ago
Board Meeting Outcome for Oucome Of Board Meeting Held Today Wednesday November 12 20255 days ago
Modified Intimation Of Board Meeting W.R.T Disclosure Of Trading Window Closure9 days ago
Board Meeting Intimation for 06Th Board Meeting To Be Held On Wednesday November 12 2025 Through Video Conferencing At 11.30 A.M 10 days ago
Upgradation Of Existing Centre At BadlapurOct 10, 2025
Non-Applicability Of Reg 23 Of SEBI (LODR) Regulations 2015 W.R.T Related Party TransactionOct 10, 2025
Non-Applicability Of CG ReportOct 10, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 10, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 27, 2025
Closure of Trading WindowSep 24, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 24, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 24, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 23, 2025
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsSep 10, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 28, 2025
Fixes Book Closure Date For 15Th AGMAug 26, 2025
Reg. 34 (1) Annual Report.Aug 26, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 21, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 21, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held Today Tuesday August 19 2025 At 12.00 NoonAug 19, 2025
Board Meeting Intimation for Board Meeting To Be Held On Tuesday August 19 2025 Through Video Conferencing At 12.00 NoonAug 13, 2025
Introduction Of In-House Molecular Department For All TestsAug 05, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 14, 2025
Appointment of Company Secretary and Compliance OfficerJun 06, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E June 06 2025 At 11.30 AM At Its Registered OfficeJun 06, 2025
Board Meeting Intimation for 02Nd Board Meeting Of The Company For FY 2025-26 At Its Registered OfficeJun 03, 2025
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerJun 02, 2025
Financial Results For 31.03.2025May 23, 2025
Undertaking For Non-Applicability Of Disclosure For RPTMay 23, 2025
Statement Of Deviation Or Variation As On March 31 2025 From Utilization Of Funds Raised Through IPOMay 23, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Friday May 23 2025 At 11.30 AM For Approval Of Financial Results As On March 31 2025.May 23, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Friday May 23 2025 At 11.30 AM For Approval Of Financial Results As On March 31 2025.May 23, 2025
Board Meeting Intimation for We Wish To Inform You That The Meeting Of The Board Of Directors Of The Company Will Be Held On Friday May 23 2025 Through Video Conferencing At 11.30 AM (IST)May 19, 2025
Non Applicability Disclosure W.R.T Large CorporateApr 16, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On March 25 2025 At The Registered Office Of The Company At 03.00 PM (IST).Mar 25, 2025
Closure of Trading WindowMar 24, 2025
Board Meeting Intimation for The Meeting Of The Board Of Directors Of The Company To Be Held On Tuesday March 25 2025 At 03.00 PM (IST) At The Registered Office Of The Company.Mar 19, 2025
Disclosure Under Regulation 30 Of SEBI (LODR) 2015.Feb 25, 2025
Reply Sought By The Exchange Under Regulation 30 Of SEBI (LODR) Regulations 2015.Feb 06, 2025
Clarification sought from Clinitech Laboratory LtdFeb 05, 2025
Integrated Filing (Governance)Jan 10, 2025
Statement Of Investor Complaints Under Regulation 13(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Jan 10, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 10, 2025
General Announcement Under Reg 30 Of SEBI (LODR)Jan 07, 2025
Submission Of Statement Of Deviation(S) Or Variation(S) Pursuant To Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Nov 13, 2024
Non Applicability Of Related Party TransactionsNov 13, 2024
Outcome Of The Board Meeting Held On Wednesday, November 13, 2024.Nov 13, 2024

Technical Indicators

RSI(14)
Neutral
45.87
ATR(14)
Less Volatile
1.93
STOCH(9,6)
Neutral
71.88
STOCH RSI(14)
Neutral
77.02
MACD(12,26)
Bullish
0.05
ADX(14)
Weak Trend
17.89
UO(9)
Bearish
50.85
ROC(12)
Uptrend And Accelerating
0.10
WillR(14)
Neutral
-43.52